Neurology 2001;56:31-36
© 2001 American Academy of Neurology
Articles
Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy
J. Rättyä, MD;,
J. Turkka, MD, PhD;,
A. J. Pakarinen, MD, PhD;,
M. Knip, MD, PhD;,
M. A. Kotila, MD, PhD;,
O. Lukkarinen, MD, PhD;,
V.V. Myllylä, MD, PhD; and
J. I.T. Isojärvi, MD, PhD.
From the Departments of Neurology (Drs. Rättyä, Turkka, Myllylä, and Isojärvi), Clinical Chemistry (Dr. Pakarinen), and Urology (Dr. Lukkarinen), University of Oulu; Medical School (Dr. Knip), University of Tampere; and Department of Neurology (Dr. Kotila), University of Helsinki, Finland.
Address correspondence and reprint requests to Dr. Johanna Rättyä, Department of Neurology, University of Oulu, Finland, Kajaanintie 50, FIN-90220 Oulu; e-mail: johanna.rattya{at}oulu.fi
BACKGROUND: Recent observations have indicated that reproductive endocrine disorders are common among women taking valproate (VPA) for epilepsy, but it is not known whether respective abnormalities develop in men taking VPA for epilepsy. Carbamazepine (CBZ) may induce endocrine disorders in men with epilepsy, but the endocrine effects of oxcarbazepine (OXC) are not known.
METHODS: Reproductive endocrine function was evaluated in 90 men taking VPA (n = 21), CBZ (n = 40), or OXC (n = 29) as monotherapy for epilepsy and in 25 healthy control men.
RESULTS: Twelve men (57%) taking VPA had increased serum androgen levels. The mean serum level of androstenedione was high in patients taking VPA. Serum levels of dehydroepiandrosterone sulfate were low, and serum concentrations of sex hormone–binding globulin (SHBG) were high in men taking CBZ. The endocrine effects of OXC seemed to be dose-dependent, because serum hormone levels were normal in patients with low OXC doses (<900 mg/day), but serum concentrations of testosterone, gonadotropins, and SHBG were high in patients with a daily OXC dose  900 mg.
CONCLUSIONS: VPA increases serum androgen concentrations in men with epilepsy. The endocrine effects of CBZ and OXC were different, because CBZ appears to decrease the bioactivity of androgens, whereas OXC does not.
This article has been cited by other articles:
|
|
|
|
 
J. A. Talbot, R. Sheldrick, H. Caswell, and S. Duncan
Sexual function in men with epilepsy: How important is testosterone?
Neurology,
April 15, 2008;
70(16):
1346 - 1352.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Artama, J.I.T. Isojarvi, and A. Auvinen
Antiepileptic drug use and birth rate in patients with epilepsy--a population-based cohort study in Finland
Hum. Reprod.,
September 1, 2006;
21(9):
2290 - 2295.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Devinsky
Neurologist-induced sexual dysfunction: Enzyme-inducing antiepileptic drugs
Neurology,
October 11, 2005;
65(7):
980 - 981.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. G. Herzog, F. W. Drislane, D. L. Schomer, P. B. Pennell, E. B. Bromfield, B. A. Dworetzky, E. L. Farina, and C. A. Frye
Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy
Neurology,
October 11, 2005;
65(7):
1016 - 1020.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. D. Anderson
Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs
Neurology,
November 23, 2004;
63(10_suppl_4):
S3 - S8.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. W. Kaplan
Reproductive health effects and teratogenicity of antiepileptic drugs
Neurology,
November 23, 2004;
63(10_suppl_4):
S13 - S23.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
M. Artama, J. I. T. Isojarvi, J. Raitanen, and A. Auvinen
Birth Rate among Patients with Epilepsy: A Nationwide Population-based Cohort Study in Finland
Am. J. Epidemiol.,
June 1, 2004;
159(11):
1057 - 1063.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. R. Gates
Epilepsy versus antiepileptic drugs and gonadal function in men
Neurology,
January 27, 2004;
62(2):
174 - 175.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Bauer, S. Blumenthal, M. Reuber, and B. Stoffel-Wagner
Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy
Neurology,
January 27, 2004;
62(2):
243 - 246.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. I.T. Isojarvi, E. Lofgren, K. S.T. Juntunen, A. J. Pakarinen, M. Paivansalo, I. Rautakorpi, and L. Tuomivaara
Effect of epilepsy and antiepileptic drugs on male reproductive health
Neurology,
January 27, 2004;
62(2):
247 - 253.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. I. T. Isojarvi
Reproductive dysfunction in women with epilepsy
Neurology,
September 1, 2003;
61(90062):
S27 - 34.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
V. Pylvanen, M. Knip, A. J. Pakarinen, J. Turkka, M. Kotila, J. Rattya, V. V. Myllyla, and J. I.T. Isojarvi
Fasting serum insulin and lipid levels in men with epilepsy
Neurology,
February 25, 2003;
60(4):
571 - 574.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Bauer, J I T Isojarvi, A G Herzog, M Reuber, D Polson, E Tauboll, P Genton, H van der Ven, B Roesing, G J Luef, et al.
Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
J. Neurol. Neurosurg. Psychiatry,
August 1, 2002;
73(2):
121 - 125.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Endocrine Effects of Antiepileptic Drugs in Men
Journal Watch Psychiatry,
February 6, 2001;
2001(206):
5 - 5.
[Full Text]
|
|
|
|
